MA
MYDA Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,000
| Closed | -$1.64M | – | 137 |
|
|
2023
Q1 | $1.64M | Buy |
2,000
+800
| +67% | +$657K | 0.62% | 35 |
|
|
2022
Q4 | $866K | Sell |
1,200
-800
| -40% | -$577K | 0.53% | 39 |
|
|
2022
Q3 | $1.38M | Buy |
+2,000
| New | +$1.38M | 0.65% | 41 |
|
|
2022
Q1 | – | Sell |
-2,400
| Closed | -$1.52M | – | 248 |
|
|
2021
Q4 | $1.52M | Sell |
2,400
-8,300
| -78% | -$5.24M | 0.4% | 69 |
|
|
2021
Q3 | $6.48M | Buy |
10,700
+6,700
| +168% | +$4.05M | 1.81% | 4 |
|
|
2021
Q2 | $2.23M | Buy |
+4,000
| New | +$2.23M | 0.56% | 47 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 208 |
|
|
2020
Q3 | – | Sell |
-4,000
| Closed | -$2.5M | – | 130 |
|
|
2020
Q2 | $2.5M | Sell |
4,000
-700
| -15% | -$437K | 1.51% | 15 |
|
|
2020
Q1 | $2.3M | Buy |
+4,700
| New | +$2.3M | 1.43% | 12 |
|